David T Teachey

David T Teachey

UNVERIFIED PROFILE

Are you David T Teachey?   Register this Author

Register author
David T Teachey

David T Teachey

Publications by authors named "David T Teachey"

Are you David T Teachey?   Register this Author

81Publications

2631Reads

17Profile Views

Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome.

Expert Rev Clin Immunol 2019 Aug 20;15(8):813-822. Epub 2019 Jun 20.

a Department of Pediatrics, Division of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine , Philadelphia , PA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/1744666X.2019.1629904DOI Listing
August 2019

Cellular therapy: Immune-related complications.

Immunol Rev 2019 07;290(1):114-126

Divisions of Hematology and Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/imr.12768DOI Listing
July 2019

Excellent outcomes for patients with B-cell precursor acute lymphoblastic leukaemia with late bone marrow relapses.

Authors:
David T Teachey

Lancet Haematol 2019 04 27;6(4):e172-e173. Epub 2019 Feb 27.

Division of Oncology, Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2352-3026(19)30032-8DOI Listing
April 2019

Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia.

Lancet Oncol 2019 Mar;20(3):e142-e154

Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30031-2DOI Listing
March 2019

Tisagenlecleucel for the treatment of B-cell acute lymphoblastic leukemia.

Expert Rev Anticancer Ther 2018 10;18(10):959-971

a Divisions of Pediatric Hematology and Oncology , Children's Hospital of Philadelphia, University of Pennsylvania, Perelman School of Medicine , Philadelphia , PA , USA.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14737140.2018.1
Publisher Site
http://dx.doi.org/10.1080/14737140.2018.1512411DOI Listing
October 2018

Hypofibrinogenemia Is Associated With Poor Outcome and Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome in Pediatric Severe Sepsis.

Pediatr Crit Care Med 2018 05;19(5):397-405

Division of Critical Care Medicine, Department of Anesthesiology and Critical Care, The Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00130478-201805000-0000
Publisher Site
http://dx.doi.org/10.1097/PCC.0000000000001507DOI Listing
May 2018

Early clinical observations on the use of imatinib mesylate in FOP: A report of seven cases.

Bone 2018 04 20;109:276-280. Epub 2017 Jul 20.

Department of Medicine, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bone.2017.07.019DOI Listing
April 2018

Toxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'.

Nat Rev Clin Oncol 2018 04 13;15(4):218. Epub 2018 Feb 13.

Department of Pediatrics and The Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2018.19DOI Listing
April 2018

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.

N Engl J Med 2018 04;378(16):1479-1493

From the Ann and Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago (A.A.T., M.K.); University of California, San Francisco, Benioff Children's Hospital, Oakland (M.C.W., E.V.), Lucile Salter Packard Children's Hospital at Stanford, Palo Alto (S.S.), and David Geffen School of Medicine, University of California, Los Angeles, Los Angeles (G.J.S.) - all in California; Children's Hospital of Philadelphia and University of Pennsylvania Perelman School of Medicine, Philadelphia (J.K., D.T.T.); Centenary Institute (J.E.J.R.), University of Sydney, Sydney Medical School (J.E.J.R., P.J.H.), and Royal Prince Alfred Hospital (J.E.J.R., P.J.H.), Camperdown, NSW, Australia; Hôpital Universitaire Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris (J.-A.R., E.M., D.M., F.L., P.B., A.M., L.C., J.-S.D., F.S., F.M., V.B., C.B., O.H., M.D.M., S.B., M.C.), Groupe Hospitalier Universitaire Ouest (J.-A.R., A.M., L.C., M.C.), IMAGINE Institute (E.M., M.S., D.M., M.C.), Université Paris Descartes (M.S., C. Poirot, S.H.-B.-A.), Université Paris Diderot (H.P., T.L.), Pierre et Marie Curie University (C. Poirot), and Hôpital Cochin (J.-F.M.), Paris, CEA University Paris-Sud, Institute of Emerging Diseases and Innovative Therapies, Fontenay-aux-Roses (E.P., Y.B., S.C., P.L.), Hôpital Louis-Mourier, Colombes (H.P., T.L.), Centre Hospitalier Intercommunal de Créteil, Créteil (C. Pondarré), and Hôpital Bicêtre, Le Kremlin-Bicêtre (S.H.-B.-A.) - all in France; Bluebird Bio, Cambridge (J.-A.R., S.S., G.V., O.N., R.W.R., D.D., A.P., L.S., M.A.), and Harvard Medical School, Brigham and Women's Hospital, Boston (P.L.) - both in Massachusetts; Ramathibodi Hospital, Mahidol University, Bangkok, Thailand (S.H., U.A., P.L.); and the National Center for Tumor Diseases-German Cancer Research Center, Heidelberg, Germany (C.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1705342DOI Listing
April 2018

Acute lymphoblastic leukaemia in 2017: Immunotherapy for ALL takes the world by storm.

Nat Rev Clin Oncol 2018 02 19;15(2):69-70. Epub 2017 Dec 19.

Department of Pediatrics, The Center for Childhood Cancer Research, Children's Hospital of Philadelphia, and the Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2017.176DOI Listing
February 2018

Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors.

Cancer Cell 2018 02;33(2):274-291.e8

Haematopoietic Stem Cell Biology Laboratory, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK; MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK; NIHR Biomedical Research Centre, Churchill Hospital, Oxford OX3 7LE, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2018.01.006DOI Listing
February 2018

Behcet Disease Initially Presenting as Deep Venous Thrombosis: A Case Report.

J Pediatr Hematol Oncol 2017 07;39(5):410-412

*Division of Oncology Departments of †Pediatrics §Pathology and Laboratory Medicine ¶Division of Hematology, The Children's Hospital of Philadelphia Departments of ‡Pediatrics ∥Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0000000000000830DOI Listing
July 2017

Monocyte lineage-derived IL-6 does not affect chimeric antigen receptor T-cell function.

Cytotherapy 2017 07 11;19(7):867-880. Epub 2017 May 11.

Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcyt.2017.04.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676485PMC
July 2017

Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia.

Crit Care Med 2017 Feb;45(2):e124-e131

1Division of Critical Care Medicine, Department of Anesthesia and Critical Care, The Children's Hospital of Philadelphia and The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 2Division of Oncology, Department of Pediatrics, The Children's Hospital of Philadelphia and The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 3Center for Cellular Immunotherapies, Department of Pathology and Laboratory Medicine, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 4Department of Biostatistics and Epidemiology, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 5Division of Hematology-Oncology, Department of Medicine, Abramson Cancer Center, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCM.0000000000002053DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5452983PMC
February 2017

T-cell acute lymphoblastic leukemia.

Hematology Am Soc Hematol Educ Program 2016 Dec;2016(1):580-588

Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2016.1.580DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142501PMC
December 2016

Cytokine Release Syndrome after Haploidentical Stem Cell Transplantation.

Biol Blood Marrow Transplant 2016 10 16;22(10):1736-1737. Epub 2016 Aug 16.

Division of Oncology, The Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.08.010DOI Listing
October 2016

The role of proteasome inhibition in the treatment of malignant and non-malignant hematologic disorders.

Expert Rev Hematol 2016 Sep 5;9(9):873-89. Epub 2016 Aug 5.

a Departments of Hematology and Oncology , Children's Hospital of Philadelphia , Philadelphia , PA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2016.1216311DOI Listing
September 2016

Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children.

Paediatr Drugs 2016 Aug;18(4):261-72

Division of Hematology, The Children's Hospital of Philadelphia, Colket Translational Research Building, Room 5016, 3501 Civic Center Boulevard, Philadelphia, PA, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40272-016-0175-3DOI Listing
August 2016

Measuring IL-6 and sIL-6R in serum from patients treated with tocilizumab and/or siltuximab following CAR T cell therapy.

J Immunol Methods 2016 07 3;434:1-8. Epub 2016 Apr 3.

University of Pennsylvania, Department of Pathology and Laboratory Medicine, Product Development & Correlative Sciences Laboratory, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2016.03.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490247PMC
July 2016

Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia.

Cancer Discov 2016 06 13;6(6):664-79. Epub 2016 Apr 13.

Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. Department of Pediatrics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Abramson Cancer Center, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Department of Pathology and Laboratory Medicine, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-16-0040DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448406PMC
June 2016

Successful Treatment of Recurrent Autoimmune Cytopenias in the Context of Sinus Histiocytosis With Massive Lymphadenopathy Using Sirolimus.

Pediatr Blood Cancer 2016 Feb 9;63(2):358-60. Epub 2015 Oct 9.

Department of Pediatrics, Baylor College of Medicine, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.25770DOI Listing
February 2016

Atypical Chronic Myeloid Leukemia in Two Pediatric Patients.

Pediatr Blood Cancer 2016 Jan 14;63(1):156-9. Epub 2015 Aug 14.

Department of Pathology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.25694
Publisher Site
http://dx.doi.org/10.1002/pbc.25694DOI Listing
January 2016

Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.

Blood 2016 Jan 26;127(1):17-28. Epub 2015 Oct 26.

Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA; Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-07-657981DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705607PMC
January 2016

CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia.

Blood 2015 Jun 21;125(26):4017-23. Epub 2015 May 21.

Division of Oncology, The Children's Hospital of Philadelphia, Department of Pediatrics, Department of Pathology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-12-580068DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4481592PMC
June 2015

Managing cytokine release syndrome associated with novel T cell-engaging therapies.

Cancer J 2014 Mar-Apr;20(2):119-22

From the *Division of Pediatric Oncology, and †Department of Pathology, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000035DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119809PMC
November 2014

Chimeric antigen receptor T cells for sustained remissions in leukemia.

N Engl J Med 2014 Oct;371(16):1507-17

From the Division of Oncology, Children's Hospital of Philadelphia (S.L.M., R.A., D.M.B., N.J.B., S.R.R., D.T.T., S.A.G.), the Departments of Pediatrics (S.L.M., R.A., D.M.B., N.J.B., S.R.R., D.T.T., S.A.G.), Biostatistics and Epidemiology (P.A.S., R.A.), and Pathology and Laboratory Medicine (J.J.M., B.L.L., C.H.J., S.A.G.), the Division of Hematology-Oncology (N.F., D.L.P.), and Abramson Cancer Center (N.F., A.C., V.E.G., Z.Z., S.F.L., Y.D.M., J.J.M., B.L.L., C.H.J., D.L.P., S.A.G.), Perelman School of Medicine, University of Pennsylvania - all in Philadelphia; and Novartis Pharmaceuticals, East Hanover, NJ (A.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1407222DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267531PMC
October 2014

Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies.

Front Oncol 2014 16;4:108. Epub 2014 May 16.

Division of Oncology, Department of Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine , Philadelphia, PA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2014.00108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032892PMC
June 2014

Toxicity management for patients receiving novel T-cell engaging therapies.

Curr Opin Pediatr 2014 Feb;26(1):43-9

Division of Pediatric Oncology, Children's Hospital of Philadelphia, University of Pennsylvania, Perelman School of Medicine, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOP.0000000000000043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198063PMC
February 2014

Targeting cytokines in ALPS: it's FAShionable.

Authors:
David T Teachey

Blood 2014 Feb;123(8):1116-8

THE CHILDREN'S HOSPITAL OF PHILADELPHIA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-01-546713DOI Listing
February 2014

Diagnosis and management of autoimmune cytopenias in childhood.

Pediatr Clin North Am 2013 Dec 5;60(6):1489-511. Epub 2013 Oct 5.

Pediatric Hematology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, 3501 Civic Center Boulevard, Philadelphia, PA 19104, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pcl.2013.08.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384653PMC
December 2013

Predicting relapse risk in childhood acute lymphoblastic leukaemia.

Br J Haematol 2013 Sep 29;162(5):606-20. Epub 2013 Jun 29.

Pediatric Hematology and Oncology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12442DOI Listing
September 2013

Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.

N Engl J Med 2013 Apr 25;368(16):1509-1518. Epub 2013 Mar 25.

Children's Hospital of Philadelphia (S.A.G., D.B., R.A., S.R.R., D.T.T., B.H., J.F.W.); the Department of Pediatrics (S.A.G., D.B., R.A., S.R.R., D.T.T.), Abramson Cancer Center (S.A.G., M.K., R.A., D.L.P., S.R.R., D.T.T., M.C.M., B.L.L., C.H.J.); and the Departments of Pathology and Laboratory Medicine (M.K., A.C., B.H., J.F.W., M.C.M., B.L.L., C.H.J.) and Medicine (D.L.P.), University of Pennsylvania - all in Philadelphia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1215134DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058440PMC
April 2013

Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study.

Clin Cancer Res 2012 Nov 17;18(21):6058-64. Epub 2012 Sep 17.

Division of Oncology and Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-3251DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008248PMC
November 2012

Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies.

Paediatr Drugs 2012 Oct;14(5):299-316

Department of Pediatrics, Division of Oncology, Childrens Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11594740-000000000-00000DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4214862PMC
October 2012

New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.

Authors:
David T Teachey

Curr Opin Pediatr 2012 Feb;24(1):1-8

Division of Pediatric Hematology, Children's Hospital of Philadelphia, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOP.0b013e32834ea739DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3673763PMC
February 2012

Rapamycin does not control hemophagocytic lymphohistiocytosis in LCMV-infected perforin-deficient mice.

Pediatr Blood Cancer 2011 Dec 16;57(7):1239-43. Epub 2011 Jun 16.

Division of Hematology/Oncology, Duke University Medical Center, Durham, North Carolina, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.23226DOI Listing
December 2011

Noninvasive bioluminescent imaging of primary patient acute lymphoblastic leukemia: a strategy for preclinical modeling.

Blood 2011 Oct 19;118(15):e112-7. Epub 2011 Aug 19.

Department of Pediatrics, Division of Oncology, Center for Childhood Cancer Research, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2011-04-34
Publisher Site
http://dx.doi.org/10.1182/blood-2011-04-346528DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204743PMC
October 2011

Autoimmune lymphoproliferative syndrome: new approaches to diagnosis and management.

Authors:
David T Teachey

Clin Adv Hematol Oncol 2011 Mar;9(3):233-5

Divisions of Hematology and Oncology, Blood and Marrow Transplant, Children’s Hospital of Philadelphia, University of Pennsylvania, School of Medicine, USA.

View Article

Download full-text PDF

Source
March 2011

Cutting edge: Lymphoproliferation caused by Fas deficiency is dependent on the transcription factor eomesodermin.

J Immunol 2010 Dec 12;185(12):7151-5. Epub 2010 Nov 12.

Abramson Family Cancer Research Institute, Division of Infectious Diseases, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1003193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997140PMC
December 2010

Somatic ALPS: a FAScinating condition.

Authors:
David T Teachey

Blood 2010 Jun;115(25):5125-6

The Children's Hospital of Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-04-278465DOI Listing
June 2010

Identifying autoimmune lymphoproliferative syndrome in children with Evans syndrome: a multi-institutional study.

Blood 2010 Mar 12;115(11):2142-5. Epub 2010 Jan 12.

Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2009-08-239525DOI Listing
March 2010

Dabigatran versus warfarin for venous thromboembolism.

Authors:
David T Teachey

N Engl J Med 2010 Mar;362(11):1050; author reply 1050-1

View Article

Download full-text PDF

Source
March 2010

Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).

Br J Haematol 2010 Jan 23;148(2):205-16. Epub 2009 Nov 23.

Children's Hospital of Philadelphia, University of Pennsylvania, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2009.07991.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929682PMC
January 2010

Treatment with sirolimus ameliorates tacrolimus-induced autoimmune cytopenias after solid organ transplant.

Pediatr Blood Cancer 2009 Dec;53(6):1114-6

Division of Hematology, Children's Hospital of Philadelphia, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.22183DOI Listing
December 2009

Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies.

Br J Haematol 2009 Jun 16;145(5):569-80. Epub 2009 Mar 16.

Division of Paediatric Hematology, Children's Hospital of Philadelphia, 3615 Civic Centre Boulevard, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2009.07657.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784662PMC
June 2009

Treatment with sirolimus results in complete responses in patients with autoimmune lymphoproliferative syndrome.

Br J Haematol 2009 Apr 4;145(1):101-6. Epub 2009 Feb 4.

Pediatric Hematology and Oncology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2009.07595.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819393PMC
April 2009

Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease.

Immunol Res 2008 ;42(1-3):84-105

Division of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, ARC 902, 3615 Civic Center Boulevard, Philadelphia, PA, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12026-008-8038-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2890314PMC
March 2009

Saddle pulmonary embolism as a complication of vasectomy.

Authors:
David T Teachey

Urology 2008 Feb;71(2):351.e5-6

Department of Pediatric Hematology, Children's Hospital of Philadelphia, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2007.10.031DOI Listing
February 2008

Targeting Notch signaling in autoimmune and lymphoproliferative disease.

Blood 2008 Jan 9;111(2):705-14. Epub 2007 Oct 9.

Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-05-087353DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2200835PMC
January 2008

Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis.

J Pediatr Hematol Oncol 2007 Aug;29(8):569-73

Department of Pediatrics, Division of Oncology, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0b013e3180f61be3DOI Listing
August 2007

In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides.

Blood 2007 Mar 26;109(5):2008-13. Epub 2006 Oct 26.

Department of Pediatrics, Division of Hematology/Oncology/Bone Marrow Transplantation, University of British Columbia and British Columbia's Children's Hospital, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2006-02-002055DOI Listing
March 2007

Neonatal MRI and neurodevelopmental outcomes.

Authors:
David T Teachey

N Engl J Med 2006 Nov;355(22):2374; author reply 2374-5

View Article

Download full-text PDF

Source
November 2006

The mTOR inhibitor CCI-779 induces apoptosis and inhibits growth in preclinical models of primary adult human ALL.

Blood 2006 Feb 29;107(3):1149-55. Epub 2005 Sep 29.

Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2005-05-1935DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1895910PMC
February 2006

Development of cold agglutinin autoimmune hemolytic anemia during treatment for pediatric acute lymphoblastic leukemia.

J Pediatr Hematol Oncol 2005 Jul;27(7):397-9

Division of Hematology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.mph.0000174031.63108.ebDOI Listing
July 2005

Cell division rates of primary human precursor B cells in culture reflect in vivo rates.

Stem Cells 2004 ;22(6):1111-20

Pathology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/stemcells.22-6-1111DOI Listing
April 2005

Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS).

Blood 2005 Mar 12;105(6):2443-8. Epub 2004 Nov 12.

Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, ARC 902, 3615 Civic Center Blvd, Philadelphia, PA 19104, USA.

View Article

Download full-text PDF

Source
http://www.bloodjournal.org/content/105/6/2443.full.pdf
Web Search
http://www.bloodjournal.org/cgi/doi/10.1182/blood-2004-09-35
Publisher Site
http://dx.doi.org/10.1182/blood-2004-09-3542DOI Listing
March 2005